Table of Content


Chapter 1 Methodology and Scope
1.1 Market scope and definition
1.2 Base estimates and working
1.3 Forecast calculations
1.4 Data sources
1.4.1 Primary
1.4.2 Secondary
1.4.2.1 Paid sources
1.4.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Global tuberculosis diagnostics test market 360 degree synopsis, 2018 – 2032
2.1.1 Regional trends
2.1.2 Test type trends
2.1.3 End-use trends
Chapter 3 Tuberculosis Diagnostics Test Industry Insights
3.1 Industry ecosystem analysis
3.2 Technology landscape
3.3 Regulatory landscape
3.4 Industry impact forces
3.4.1 Growth drivers
3.4.1.1 Rising burden of tuberculosis globally
3.4.1.2 Advancement in tuberculosis diagnostics techniques
3.4.1.3 Increasing awareness and screening programs regarding tuberculosis
3.4.1.4 Surge in Point-of-Care testing (POCT)
3.4.2 Industry pitfalls and challenges
3.4.2.1 Limited sensitivity and specificity
3.4.2.2 Stringent regulatory scenario
3.5 Growth potential analysis
3.5.1 By test type
3.5.2 By end-use
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis, 2023
4.3 Competitive analysis of major market players, 2023
4.4 Competitive positioning matrix, 2023
4.5 Strategic outlook matrix, 2023
Chapter 5 Tuberculosis Diagnostics Test Market Size and Forecast, By Test Type, 2018-2032 (USD Million)
5.1 Key trends, by test type
5.2 Radiographic method
5.3 Diagnostic laboratory methods
5.3.1 Microscopy
5.3.2 Culture-based techniques
5.3.3 Serological tests
5.4 Molecular diagnostics
5.4.1 Polymerase chain reaction (PCR)
5.4.2 Nucleic acid amplification tests (NAAT)
5.4.3 GeneXpert MTB/RIF
5.5 Detection of latent infection
5.5.1 Tuberculin skin test (TST)
5.5.2 Interferon-gamma release assays (IGRAs)
5.6 Cytokine detection assay
5.7 Detection of drug resistance (DST)
5.8 Phage assay
5.9 Other test types
Chapter 6 Tuberculosis Diagnostics Test Market Size and Forecast, By End-use, 2018-2032 (USD Million)
6.1 Key trends, by end-use
6.2 Pathological laboratories
6.3 Point of care testing (POCT)
6.4 Other end users
Chapter 7 Tuberculosis Diagnostics Test Market Size and Forecast, By Region, 2018-2032 (USD Million)
7.1 Key trends, by region
7.2 North America
7.2.1 U.S.
7.2.2 Canada
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Australia
7.4.5 South Korea
7.4.6 Rest of Asia Pacific
7.5 Latin America
7.5.1 Brazil
7.5.2 Mexico
7.5.3 Argentina
7.5.4 Rest of Latin America
7.6 Middle East and Africa
7.6.1 Saudi Arabia
7.6.2 South Africa
7.6.3 UAE
7.6.4 Rest of Middle East and Africa
Chapter 8 Company Profiles
8.1 Abbott Laboratories
8.2 Becton, Dickinson and Company (BD)
8.3 bioMerieux SA
8.4 Cepheid (Danaher Corporation)
8.5 F. Hoffmann-La Roche Ltd.
8.6 Hologic, Inc.
8.7 Hain Lifescience GmbH
8.8 Oxford Immunotec (PerkinElmer)
8.9 Qiagen N.V.
8.10 Roche Molecular Systems Inc.
8.11 Siemens Healthineers AG
8.12 Thermo Fisher Scientific Inc.